Ariadna Vicente Parra

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Circulating Tumor

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Javier Gil-Etayo, Daniel Arroyo-Sánchez, Jairo Eduardo Niño Ramírez, Ariadna Vicente Parra, Amalia Tejeda Velarde
Two new HLA-DQB1*03:02:01 variants with substitutions in intron 2: HLA-DQB1*03:02:01:19 and -DQB1*03:02:01:21. HLA 103 (5) (2024)
Francisco Javier Gil-Etayo, Daniel Arroyo-Sánchez, Jairo Eduardo Niño Ramírez, Ariadna Vicente Parra, Amalia Tejeda Velarde
Two new HLA-DQB1*03:02:01 variants with substitutions in intron 2: HLA-DQB1*03:02:01:19 and -DQB1*03:02:01:21. HLA 103 (5) (2024)
Francisco Javier Gil-Etayo, Jairo Eduardo Niño Ramírez, Ariadna Vicente Parra, Daniel Arroyo-Sánchez, Amalia Tejeda Velarde
Characterization of seven novel HLA-DPA1*01:03:01 non-coding variants by next-generation sequencing. HLA 103 (2) (2024)
Francisco Javier Gil-Etayo, Jairo Eduardo Niño Ramírez, Ariadna Vicente Parra, Daniel Arroyo-Sánchez, Amalia Tejeda Velarde
Characterization of seven novel HLA-DPA1*01:03:01 non-coding variants by next-generation sequencing. HLA 103 (2) (2024)
Jairo Eduardo Niño Ramírez, Francisco Javier Gil-Etayo, Ariadna Vicente Parra, Miriam Santero, Amalia Tejeda Velarde
Transitions in intronic regions result in two novel HLA-DQB1 alleles: -DQB1*05:02:01:13 and -DQB1*05:02:01:14. HLA (2023)
Jairo Eduardo Niño Ramírez, Francisco Javier Gil-Etayo, Ariadna Vicente Parra, Miriam Santero, Amalia Tejeda Velarde
The novel HLA-DQB1*03:493 allele, the first with glutamic acid at position-10 in the leader peptide. HLA 100 (6) (2022)